[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Gong et al., 2016 - Google Patents

Interleukin‐22 might act as a double‐edged sword in type 2 diabetes and coronary artery disease

Gong et al., 2016

View PDF @Full View
Document ID
17116801018189593175
Author
Gong F
Wu J
Zhou P
Zhang M
Liu J
Liu Y
Lu X
Liu Z
Publication year
Publication venue
Mediators of inflammation

External Links

Snippet

Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are both characterized by chronic low‐grade inflammation. The role of Th17 and its related cytokines in T2DM and CAD is unclear. Here we investigated the serum levels of five Th17‐related cytokines (IL‐17 …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders

Similar Documents

Publication Publication Date Title
Gong et al. Interleukin‐22 might act as a double‐edged sword in type 2 diabetes and coronary artery disease
Lau et al. Type 2 diabetes is associated with the accumulation of senescent T cells
Tang et al. C‐reactive protein and ageing
Scirica et al. The verdict is still out
Lin et al. Circulating Th22 and Th9 levels in patients with acute coronary syndrome
Lu et al. Circulating secreted frizzled‐related protein 5 (Sfrp5) and wingless‐type MMTV integration site family member 5a (Wnt5a) levels in patients with type 2 diabetes mellitus
Braunersreuther et al. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice
Simon et al. Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction
Giovannini et al. Interleukin‐6, C‐reactive protein, and tumor necrosis factor‐alpha as predictors of mortality in frail, community‐living elderly individuals
Franscini et al. Gene expression profiling of inflamed human endothelial cells and influence of activated protein C
Rocha et al. Obesity, inflammation, and atherosclerosis
Demyanets et al. Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome
Min et al. Alterations in monocyte CD16 in association with diabetes complications
Boekholdt et al. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study
Rothenbacher et al. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers
Eid et al. Interleukin-17 and interferon-γ are produced concomitantly by human coronary artery–infiltrating T cells and act synergistically on vascular smooth muscle cells
Shen et al. The potential long‐term effect of previous schistosome infection reduces the risk of metabolic syndrome among C hinese men
Liu et al. Increased Th17 cell frequency concomitant with decreased Foxp3+ Treg cell frequency in the peripheral circulation of patients with carotid artery plaques
Lam et al. Inflammatory mediator profiling reveals immune properties of chemotactic gradients and macrophage mediator production inhibition during thioglycollate elicited peritoneal inflammation
Wang et al. Circulating Levels of Betatrophin and Irisin Are Not Associated with Pancreatic β‐Cell Function in Previously Diagnosed Type 2 Diabetes Mellitus Patients
Wedemeyer et al. Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosa
Careccia et al. Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy
Zheng et al. BAFF promotes proliferation of human mesangial cells through interaction with BAFF-R
Gasbarrino et al. Decreased adiponectin-mediated signaling through the AdipoR2 pathway is associated with carotid plaque instability
Zhu et al. Serum galectin‐9 levels are associated with coronary artery disease in chinese individuals